Literature DB >> 1648336

c-fos and c-myc oncoprotein expression in human hepatocellular carcinomas.

P Arbuthnot1, M Kew, W Fitschen.   

Abstract

Amounts of the proteins encoded by the two oncogenes c-myc and c-fos have been compared in seven specimens of hepatocellular carcinoma and two normal liver samples using a Western blot procedure. It was found that with the exception of one tumour, the amount of these proteins was markedly increased in the tumours when compared to the normal specimens. Furthermore, there appeared to be elevated c-myc and c-fos mRNA concentrations in the tumours which correlated with the protein levels. This is the first report of such a correlation in human hepatocellular carcinoma. We propose that transactivation of these oncogenes may in part be responsible for transformation in hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1648336

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  Potential roles of tumor suppressor genes and microsatellite instability in hepatocellular carcinogenesis in southern African blacks.

Authors:  Lewis R Roberts; Nicholas F LaRusso
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

2.  Immunohistochemical analysis of p53, cyclinD1, RB1, c-fos and N-ras gene expression in hepatocellular carcinoma in Iran.

Authors:  S J Moghaddam; E N Haghighi; S Samiee; N Shahid; A R Keramati; S Dadgar; M R Zali
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

3.  Expression of c-myc promoter binding protein (MBP-1), a novel eukaryotic repressor gene, in cirrhosis and human hepatocellular carcinoma.

Authors:  X Fan; H Solomon; K Schwarz; M C Kew; R B Ray; A M Di Bisceglie
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

4.  A comprehensive analysis of the dynamic biological networks in HCV induced hepatocarcinogenesis.

Authors:  Bing He; Hao Zhang; Tieliu Shi
Journal:  PLoS One       Date:  2011-04-19       Impact factor: 3.240

5.  MiR-449a suppresses the epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by multiple targets.

Authors:  Shu-Peng Chen; Bao-Xin Liu; Jie Xu; Xiao-Feng Pei; Yi-Ji Liao; Feng Yuan; Fang Zheng
Journal:  BMC Cancer       Date:  2015-10-15       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.